Pharmacokinetic Evaluation of Intranasal Nalmefene Using Three Dosing Regimens
Status:
Completed
Trial end date:
2021-11-22
Target enrollment:
Participant gender:
Summary
This study is to compare the pharmacokinetics (how the body absorbs, breaks down and
eliminates drug from your body) of nalmefene when given as a single dose intranasally
(IN;into the nose), as a single dose in each nostril and as two doses in one nostrils; and to
evaluate the safety and tolerability of nalmefene IN.